Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Updates on the surface antigens of basophils: CD16 on basophils of patients with respiratory or insect venom allergy and the rejection of CD203c and CD63 externalization decoupling by bisindolylmaleimides

P. Heneberg, K. Riegerová, A. Říhová, D. Šimčíková, P. Kučera,

. 2019 ; 49 (1) : 54-67. [pub] 20181030

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc20025968

BACKGROUND: CD16 was previously suggested to be a new marker of basophils that is subject to downregulation by FcεRI crosslinking. Certain compounds, including supraoptimal concentrations of the PKC inhibitors, bisindolylmaleimides, decouple the release of granules containing CD203c, CD63 and histamine, and may thus help to identify the mechanisms related to the CD16 externalization. OBJECTIVE: We hypothesized that CD16 is differentially expressed on the surface of basophils in patients with birch pollen or insect venom allergy and is subject to a regulation in response to allergens. We also employed CD203c and CD63 externalization decoupling by bisindolylmaleimides. METHODS: We performed a basophil activation test coupled with CD16 and histamine detection using cells isolated from patients with allergy to birch pollen or insect venom and negative controls. We employed two PKC inhibitors, bisindolylmaleimide II and Ro 31-8220 at their supraoptimal concentrations and, after difficulties reproducing previously published data, we analyzed the fluorescence of these inhibitors alone. We identified the CD16 isoforms by sequencing nested RT-PCR amplicons from flow cytometry sorted basophils and by cleaving the CD16b GPI anchor using a phospholipase C. RESULTS: We provide the first evidence that CD16a is expressed as a surface antigen on a small subpopulation of human basophils in patients with respiratory and insect venom allergy, and this antigen shows increased surface expression following allergen challenge or FcεRI crosslinking. We rejected the apparent decoupling of the surface expression of basophil activation markers following the administration of bisindolylmaleimides. CONCLUSIONS & CLINICAL RELEVANCE: The inclusion of αCD16 in negative selection cocktails selects against a subset of basophils that are CD16+ or CD16dim . Using CD16dim basophils and unstained leucocytes, we show that previous studies with supraoptimal concentrations of bisindolylmaleimides are likely flawed and are not associated with the differential expression of CD203c and CD63.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025968
003      
CZ-PrNML
005      
20201222154233.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/cea.13288 $2 doi
035    __
$a (PubMed)30288810
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Heneberg, Petr $u 2nd Department of Internal Medicine, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
245    10
$a Updates on the surface antigens of basophils: CD16 on basophils of patients with respiratory or insect venom allergy and the rejection of CD203c and CD63 externalization decoupling by bisindolylmaleimides / $c P. Heneberg, K. Riegerová, A. Říhová, D. Šimčíková, P. Kučera,
520    9_
$a BACKGROUND: CD16 was previously suggested to be a new marker of basophils that is subject to downregulation by FcεRI crosslinking. Certain compounds, including supraoptimal concentrations of the PKC inhibitors, bisindolylmaleimides, decouple the release of granules containing CD203c, CD63 and histamine, and may thus help to identify the mechanisms related to the CD16 externalization. OBJECTIVE: We hypothesized that CD16 is differentially expressed on the surface of basophils in patients with birch pollen or insect venom allergy and is subject to a regulation in response to allergens. We also employed CD203c and CD63 externalization decoupling by bisindolylmaleimides. METHODS: We performed a basophil activation test coupled with CD16 and histamine detection using cells isolated from patients with allergy to birch pollen or insect venom and negative controls. We employed two PKC inhibitors, bisindolylmaleimide II and Ro 31-8220 at their supraoptimal concentrations and, after difficulties reproducing previously published data, we analyzed the fluorescence of these inhibitors alone. We identified the CD16 isoforms by sequencing nested RT-PCR amplicons from flow cytometry sorted basophils and by cleaving the CD16b GPI anchor using a phospholipase C. RESULTS: We provide the first evidence that CD16a is expressed as a surface antigen on a small subpopulation of human basophils in patients with respiratory and insect venom allergy, and this antigen shows increased surface expression following allergen challenge or FcεRI crosslinking. We rejected the apparent decoupling of the surface expression of basophil activation markers following the administration of bisindolylmaleimides. CONCLUSIONS & CLINICAL RELEVANCE: The inclusion of αCD16 in negative selection cocktails selects against a subset of basophils that are CD16+ or CD16dim . Using CD16dim basophils and unstained leucocytes, we show that previous studies with supraoptimal concentrations of bisindolylmaleimides are likely flawed and are not associated with the differential expression of CD203c and CD63.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a jedy členovců $x toxicita $7 D001180
650    _2
$a bazofily $x imunologie $x patologie $7 D001491
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a GPI-vázané proteiny $x imunologie $7 D058851
650    _2
$a lidé $7 D006801
650    _2
$a alergie $x imunologie $x patologie $7 D006967
650    _2
$a indoly $x chemie $7 D007211
650    _2
$a kousnutí a bodnutí hmyzem $x imunologie $x patologie $7 D007299
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a maleimidy $x chemie $7 D008301
650    _2
$a lidé středního věku $7 D008875
650    _2
$a fosfodiesterasy $x imunologie $7 D010727
650    _2
$a pyrofosfatasy $x imunologie $7 D011755
650    _2
$a receptory IgG $x imunologie $7 D017452
650    _2
$a antigeny CD63 $x imunologie $7 D060149
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Riegerová, Kamila $u Department of Immunology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Říhová, Adéla $u Department of Immunology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Šimčíková, Daniela $u 2nd Department of Internal Medicine, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Kučera, Petr $u Department of Immunology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
773    0_
$w MED00009468 $t Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology $x 1365-2222 $g Roč. 49, č. 1 (2019), s. 54-67
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30288810 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222154228 $b ABA008
999    __
$a ok $b bmc $g 1600113 $s 1116654
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 49 $c 1 $d 54-67 $e 20181030 $i 1365-2222 $m Clinical and experimental allergy $n Clin Exp Allergy $x MED00009468
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Archiving options